Dr. Reddy’s Signs Licensing Agreement with Takeda for GastrointestinalDrug
New Delhi: Dr. Reddy's Laboratories announced on Thursday that it has signed a licensingagreement with Takeda Pharmaceutical Company to commercialize Vonoprazan tablets inIndia. Vonoprazan is an innovative, orally active potassium-competitive acid blocker (PCAB)used for treating
Read More